{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:29:03Z","timestamp":1768807743468,"version":"3.49.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Japan Society for the Promotion of Science KAKENHI Grant","award":["23791972"],"award-info":[{"award-number":["23791972"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0237330","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T18:22:14Z","timestamp":1597170134000},"page":"e0237330","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results"],"prefix":"10.1371","volume":"15","author":[{"given":"Mio","family":"Matsubara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2894-0454","authenticated-orcid":true,"given":"Yoichi","family":"Sakurada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-8503","authenticated-orcid":true,"given":"Kenji","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"issue":"1","key":"pone.0237330.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"LA Yannuzzi","year":"1990","journal-title":"Retina"},{"issue":"2","key":"pone.0237330.ref002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"RF Spaide","year":"1995","journal-title":"Retina"},{"issue":"2","key":"pone.0237330.ref003","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/ceo.13114","article-title":"Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of 'expanded spectra'\u2014a review","volume":"46","author":"KK Dansingani","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"pone.0237330.ref004","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/IAE.0b013e31826ffe9d","article-title":"Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration","volume":"33","author":"Y Sakurada","year":"2013","journal-title":"Retina"},{"issue":"1","key":"pone.0237330.ref005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000365487","article-title":"Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration","volume":"53","author":"Y Sakurada","year":"2015","journal-title":"Ophthalmic Res"},{"key":"pone.0237330.ref006","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1038\/ncomms7063","article-title":"New loci and coding variants confer risk for age-related macular degeneration in East Asians","volume":"6","author":"CY Cheng","year":"2015","journal-title":"Nat Commun"},{"issue":"6","key":"pone.0237330.ref007","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ng.3546","article-title":"A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy","volume":"48","author":"L Huang","year":"2016","journal-title":"Nat Genet"},{"issue":"1","key":"pone.0237330.ref008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"I Maruko","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"pone.0237330.ref009","doi-asserted-by":"crossref","first-page":"e0149978","DOI":"10.1371\/journal.pone.0149978","article-title":"Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration","volume":"11","author":"Y Sakurada","year":"2016","journal-title":"PLoS One."},{"issue":"9","key":"pone.0237330.ref010","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1089\/jop.2013.0044","article-title":"Two-year results of photodynamic therapy with or without intravitreal ranibizumab for polypoidal choroidal vasculopathy","volume":"29","author":"Y Sakurada","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"pone.0237330.ref011","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00417-016-3467-y","article-title":"Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy","volume":"255","author":"W Kikushima","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"pone.0237330.ref012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10384-016-0479-4","article-title":"Retreatment of polypoidal choroidal vasculopathy after photodynamic therapy combined with intravitreal ranibizumab","volume":"61","author":"W Kikushima","year":"2017","journal-title":"Jpn J Ophthalmol"},{"issue":"10","key":"pone.0237330.ref013","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00417-017-3718-6","article-title":"Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy","volume":"255","author":"M Morimoto","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"pone.0237330.ref014","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10384-018-0636-z","article-title":"The 24-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy","volume":"63","author":"S Nakai","year":"2019","journal-title":"Jpn J Ophthalmol"},{"issue":"11","key":"pone.0237330.ref015","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial","volume":"135","author":"A Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"pone.0237330.ref016","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"A Koh","year":"2012","journal-title":"Retina"},{"issue":"4","key":"pone.0237330.ref017","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/IAE.0000000000001689","article-title":"Disease Expression in Nonexudative Age-Related Macular Degeneration Varies with Choroidal Thickness","volume":"38","author":"RF Spaide","year":"2018","journal-title":"Retina"},{"issue":"2","key":"pone.0237330.ref018","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-016-3452-5","article-title":"Investigation of precursor lesions of polypoidal choroidal vasculopathy using contralateral eye findings","volume":"255","author":"SW Kang","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"pone.0237330.ref019","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/ceo.13438","article-title":"Choroidal morphology under pachydrusen.","volume":"47","author":"J Baek","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"pone.0237330.ref020","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00417-019-04284-4","article-title":"Clinical characteristics of pachydrusen in central serous chorioretinopathy","volume":"257","author":"H Matsumoto","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"pone.0237330.ref021","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.oret.2018.06.014","article-title":"Association between Choroidal Thickness and Drusen Subtypes in Age-Related Macular Degeneration","volume":"2","author":"CMG Cheung","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"pone.0237330.ref022","article-title":"Drusen Subtypes and Choroidal Characteristics in Asian Eyes with Typical Neovascular Age-Related Macular Degeneration","author":"J Lee","year":"2018","journal-title":"Retina"},{"issue":"1","key":"pone.0237330.ref023","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1038\/s41598-019-48494-6","article-title":"Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration","volume":"9","author":"Y Fukuda","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"pone.0237330.ref024","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1167\/iovs.18-25124","article-title":"Drusen and Age-Related Scattered Hypofluorescent Spots on Late-Phase Indocyanine Green Angiography, a Candidate Correlate of Lipid Accumulation","volume":"59","author":"L Chen","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"pone.0237330.ref025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0002-9394(14)70826-8","article-title":"Indocyanine green angiography of drusen","volume":"124","author":"JJ Arnold","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"pone.0237330.ref026","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","article-title":"The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17","volume":"123","author":"MD Davis","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"pone.0237330.ref027","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.preteyeres.2016.04.008","article-title":"Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes","volume":"53","author":"KN Khan","year":"2016","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"pone.0237330.ref028","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s10384-019-00680-9","article-title":"Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case","volume":"63","author":"Y Sakurada","year":"2019","journal-title":"Jpn J Ophthalmol"},{"key":"pone.0237330.ref029","article-title":"Clinical characteristics of cuticular drusen in the Japanese population","author":"Y Sakurada","year":"2019","journal-title":"Jpn J Ophthalmol"},{"issue":"10","key":"pone.0237330.ref030","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1097\/IAE.0000000000001427","article-title":"Choroidal Thickness as a Prognostic Factor of Photodynamic Therapy with Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy","volume":"37","author":"Y Sakurada","year":"2017","journal-title":"Retina"},{"issue":"8","key":"pone.0237330.ref031","first-page":"1509","article-title":"Vascular Hyperpermeability as a Predictor of Treatment Response for Polypoidal Choroidal Vasculopathy","volume":"38","author":"Y Yanagi","year":"2018","journal-title":"ChoroidalRetina"},{"issue":"8","key":"pone.0237330.ref032","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","article-title":"Digital indocyanine green videoangiography of central serous chorioretinopathy","volume":"112","author":"DR Guyer","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"pone.0237330.ref033","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1097\/IAE.0000000000002294","article-title":"Association between Choroidal Caverns and Choroidal Vascular Hyperpermeability in Eyes with Pachychoroid Diseases","volume":"38","author":"Y Sakurada","year":"2018","journal-title":"Retina"},{"issue":"8","key":"pone.0237330.ref034","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/IAE.0000000000000964","article-title":"Genetic Factors Associated with Choroidal Vascular Hyperpermeability and Subfoveal Choroidal Thickness in Polypoidal Choroidal Vasculopathy","volume":"36","author":"S Yoneyama","year":"2016","journal-title":"Retina"},{"issue":"11","key":"pone.0237330.ref035","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.ophtha.2015.06.053","article-title":"Factors Associated with Recurrence of Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor Treatment: A Retrospective Cohort Study","volume":"122","author":"Y Kuroda","year":"2015","journal-title":"Ophthalmology"},{"key":"pone.0237330.ref036","doi-asserted-by":"crossref","first-page":"44020","DOI":"10.1038\/srep44020","article-title":"Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration","volume":"7","author":"W Kikushima","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0237330.ref037","doi-asserted-by":"crossref","first-page":"16461","DOI":"10.1038\/s41598-017-16476-1","article-title":"Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy","volume":"7","author":"W Kikushima","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0237330.ref038","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00417-017-3847-y","article-title":"AREDS simplified severity scale as a predictive factor for response to aflibercept therapy for typical neovascular age-related macular degeneration","volume":"256","author":"Y Sakurada","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T18:23:50Z","timestamp":1597170230000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237330"}},"subtitle":[],"editor":[{"given":"Manuel Alberto de Almeida e Sousa","family":"Falc\u00e3o","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0237330","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]}}}